These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11576707)

  • 1. Therapy of localized non-small cell lung cancer (take home messages).
    Baumann M; Stamatis G; Thomas M
    Lung Cancer; 2001 Sep; 33 Suppl 1():S47-9. PubMed ID: 11576707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages.
    Scagliotti G
    Lung Cancer; 2002 Dec; 38 Suppl 3():S23-9. PubMed ID: 12468140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
    Belani CP; Ramanathan RK
    Chest; 1998 Jan; 113(1 Suppl):53S-60S. PubMed ID: 9438691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An historical perspective of multi-modality treatment for resectable non-small cell lung cancer.
    Jaklitsch MT; Strauss GM; Healey EA; DeCamp MM; Liptay MJ; Sugarbaker DJ
    Lung Cancer; 1995 Jun; 12 Suppl 2():S17-32. PubMed ID: 7551946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in completely resected non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Curr Oncol Rep; 2003 Jul; 5(4):318-25. PubMed ID: 12781075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
    Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current development of adjuvant treatment of non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Clin Lung Cancer; 2004 Dec; 6 Suppl 2():S63-70. PubMed ID: 15638960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage II non-small cell lung cancer.
    Scott WJ; Howington J; Movsas B;
    Chest; 2003 Jan; 123(1 Suppl):188S-201S. PubMed ID: 12527579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
    Bunn PA; Mault J; Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):119S-122S. PubMed ID: 10777465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality treatment of non-small-cell lung cancer stages I-III (take home messages).
    Rübe C; Fleckenstein J
    Lung Cancer; 2004 Aug; 45 Suppl 2():S139-41. PubMed ID: 15552794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surgery in N2 NSCLC: pros.
    Shien K; Toyooka S
    Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery.
    Hancock JG; Rosen JE; Antonicelli A; Moreno A; Kim AW; Detterbeck FC; Boffa DJ
    Ann Thorac Surg; 2015 Feb; 99(2):406-13. PubMed ID: 25528723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.